Simplex Trading
LKFT

Simplex Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Simplex Trading’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$3.27K – 9464
2025
Q4 		$3.27K Hold
100
– – ﹤0.01% 7643
2025
Q3 		$3K Sell
100
-39,800
-100% -$1.27M ﹤0.01% 8502
2025
Q2 		$1.12M Buy
39,900
+39,000
+4,333% +$1.05M ﹤0.01% 2664
2025
Q1 		$22K Sell
900
-15,300
-94% -$387K ﹤0.01% 6502
2024
Q4 		$445K Buy
16,200
+11,600
+252% +$323K ﹤0.01% 3669
2024
Q3 		$132K Buy
4,600
+3,500
+318% +$95.3K ﹤0.01% 4943
2024
Q2 		$27K Hold
1,100
– – ﹤0.01% 6635
2024
Q1 		$35K Sell
1,100
-13,900
-93% -$517K ﹤0.01% 6602
2023
Q4 		$609K Sell
15,000
-11,400
-43% -$420K ﹤0.01% 3492
2023
Q3 		$912K Buy
26,400
+10,200
+63% +$397K ﹤0.01% 2759
2023
Q2 		$658K Sell
16,200
-45,400
-74% -$1.85M ﹤0.01% 3023
2023
Q1 		$2.38M Buy
61,600
+21,700
+54% +$892K ﹤0.01% 1798
2022
Q4 		$1.77M Buy
39,900
+25,200
+171% +$1.06M ﹤0.01% 1966
2022
Q3 		$626K Sell
14,700
-700
-5% -$35.9K ﹤0.01% 3202
2022
Q2 		$859K Sell
15,400
-11,900
-44% -$706K ﹤0.01% 2792
2022
Q1 		$1.69M Buy
27,300
+8,200
+43% +$502K ﹤0.01% 2283
2021
Q4 		$1.05M Sell
19,100
-8,600
-31% -$449K ﹤0.01% 2789
2021
Q3 		$1.94M Hold
27,700
– – ﹤0.01% 2187
2021
Q2 		$1.91M Buy
27,700
+27,471
+11,996% +$2.1M ﹤0.01% 2227
2021
Q1 		$1.76M Buy
+229
New +$21.1K ﹤0.01% 1750
2020
Q4 		– Sell
-11
Closed -$156K – 8582
2020
Q3 		$156K Sell
11
-183
-94% -$30.5K ﹤0.01% 4404
2020
Q2 		$3.83M Sell
194
-151
-44% -$31.3K 0.01% 1023
2020
Q1 		$6.76M Buy
345
+223
+183% +$48K 0.01% 555
2019
Q4 		$2.52M Buy
122
+9
+8% +$1.66K 0.01% 1277
2019
Q3 		$1.73M Buy
113
+69
+157% +$11.3K ﹤0.01% 1454
2019
Q2 		$567K Sell
44
-333
-88% -$39.5K ﹤0.01% 2453
2019
Q1 		$4.44M Buy
377
+376
+37,600% +$37.9K 0.01% 759
2018
Q4 		$9K Sell
1
-11
-92% -$1.11K ﹤0.01% 5898
2018
Q3 		$134K Buy
+12
New +$1.27K ﹤0.01% 4108
2018
Q2 		– Sell
-5
Closed -$11K – 7534
2018
Q1 		$11K Buy
+5
New +$539 ﹤0.01% 3950

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's LKFT Position: Q1 2026 in Review

Simplex Trading increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9,666% in Q1 2026, buying an estimated $237K and bringing the position to 7,227 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #4214.

Simplex Trading first reported a position in LKFT in Q2 2017 and has held it in 18 quarters since. The position peaked at $3.73M in Q2 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Simplex Trading held 7,227 shares of Lakefront Biotherapeutics American Depositary Shares worth $217K as of Q1 2026.
  • Simplex Trading bought 7,153 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $237K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4214 holding.
  • Simplex Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and has held it in 18 quarters since.
  • Simplex Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.73M in Q2 2020.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.